FDA Brief

Company record

Naseem A. Jaffrani, M.D.

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Naseem A. Jaffrani, M.D..

Warning letters

  1. Naseem A. Jaffrani, M.D.

    FDA says clinical investigator Dr. Naseem Jaffrani failed to report serious adverse events to sponsors within 24 hours in two drug trials.

    High risk